Antibody against neoplastic plasma cells. II. Suppressive effect on antibody-producing cells.
D000042:Absorption; D000818:Animals; D000917:Antibody Formation; D000918:Antibody Specificity; D000921:Antibody-Producing Cells; D000941:Antigens; D002645:Chickens; D003165:Complement System Proteins; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006462:Hemolytic Plaque Technique; D007106:Immune Sera; D007117:Immunization, Secondary; D007165:Immunosuppression Therapy; D007668:Kidney / Q000276:immunology; D008099:Liver / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D009101:Multiple Myeloma / Q000276:immunology*; D010950:Plasma Cells / Q000276:immunology*; D011817:Rabbits; D012756:Sheep; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology
D000941:Antigens; D007106:Immune Sera; D003165:Complement System Proteins